Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

1.89
-0.0100-0.53%
Post-market: 1.890.00000.00%19:14 EDT
Volume:49.78K
Turnover:95.22K
Market Cap:11.84M
PE:-0.10
High:1.94
Open:1.93
Low:1.89
Close:1.90
Loading ...

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress

GlobeNewswire
·
02 Dec 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

ADRs End Lower; Evaxion Biotech A/S Declines 26%

Dow Jones
·
14 Nov 2024

Evaxion Biotech Appeals Nasdaq Delisting Decision

TIPRANKS
·
13 Nov 2024

Evaxion Receives and Appeals Delisting Determination From Nasdaq, Remains Committed to Nasdaq Listing

THOMSON REUTERS
·
13 Nov 2024

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

GlobeNewswire
·
13 Nov 2024

Evaxion Biotech Advances CMV Vaccine with AI Innovation

TIPRANKS
·
13 Nov 2024

European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading

MT Newswires Live
·
13 Nov 2024

EVAX Racks up Positive Test Results

Zacks Small Cap Research
·
12 Nov 2024

BRIEF-Evaxion Announces Positive Preclinical Data For Cytomegalovirus Vaccine Program EVX-V1

Reuters
·
12 Nov 2024

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

GlobeNewswire
·
12 Nov 2024

European Equities Traded in the US as American Depositary Move Higher in Monday Trading

MT Newswires Live
·
12 Nov 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday

MT Newswires Live
·
01 Nov 2024

Evaxion Biotech Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Nov 2024

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
01 Nov 2024

Evaxion Biotech Reports Q3 Progress and Financials

TIPRANKS
·
01 Nov 2024